Dexrazoxane Intravenous and Hyaluronidase and rituximab
Determining the interaction of Dexrazoxane Intravenous and Hyaluronidase and rituximab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Hyaluronidase and trastuzumab
- Dexrazoxane Intravenous-Hyaluronidase injection
- Dexrazoxane Intravenous-Hyaluronidase Injection (Human)
- Dexrazoxane Intravenous-Hyaluronidase Subcutaneous, Injection
- Dexrazoxane Intravenous-Hyate:C
- Dexrazoxane Intravenous-Hybrisil
- Hyaluronidase and rituximab-Dextenza Insert
- Hyaluronidase and rituximab-Dextenza intraocular
- Hyaluronidase and rituximab-Dextran 40
- Hyaluronidase and rituximab-Dextran 70 6% in 5% Dextrose high molecular weight
- Hyaluronidase and rituximab-Dextran 75
- Hyaluronidase and rituximab-Dextran high molecular weight